HomeCompaniesProfile

Talus Bio

Discovering drugs that target the DNA regulome 


Company Size

11 - 50 employees

Year Founded

2020


About Talus Bio

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Founders & Key People

Alex Federation

Alex Federation

Founder, Talus Bio

Lindsay Pino

Lindsay Pino

Founder, Talus Bio

Share This Profile

More Companies

Secured

Tools for Sneaker, NFT & web3 investors

Prodigal

Lending Intelligence Software

Journey

No code platform for sales to tell better stories and win more deals.

Novig

America's #1 Sports Prediction Market

hypcloud

A tech-enabled commercial mortgage broker. hypcloud allows property…

Dover

Your startup's all-in-one recruiting solution

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.